ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,226,831 | +60.8% | 113,788 | +31.1% | 0.66% | +58.2% |
| Q3 2022 | $1,385,000 | +132.4% | 86,785 | +232.6% | 0.42% | +210.4% |
| Q3 2020 | $596,000 | +61.1% | 26,090 | +47.6% | 0.13% | +48.9% |
| Q2 2020 | $370,000 | +26.3% | 17,680 | +48.6% | 0.09% | +233.3% |
| Q3 2018 | $293,000 | -0.3% | 11,897 | -20.6% | 0.03% | 0.0% |
| Q2 2018 | $294,000 | +4.6% | 14,982 | 0.0% | 0.03% | +3.8% |
| Q1 2018 | $281,000 | – | 14,982 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |